Search results for "Population"

showing 10 items of 9945 documents

Rapid Steroid Withdrawal after Renal Transplantation Reduces Mortality: Five Year Follow-Up of a Randomized Controlled Trial (Harmony Study) Confirms…

2021

Background: We previously reported excellent efficacy and improved safety aspects of rapid steroid withdrawal (RSWD) in the randomized controlled one year “Harmony” trial, in which 587 predominantly deceased-donor kidney transplant recipients were randomized either to basiliximab or rabbit ATG induction therapy and compared to standard immunosuppressive therapy consisting of basiliximab, low tacrolimus once daily, mycophenolate mofetil, and corticosteroids. Methods: Following the end of the original one-year study period, patients were asked to participate in the observational follow-up (FU) study examining most of the end points of the original study. Hereby, de novo incidences between yea…

medicine.medical_specialtyeducation.field_of_studyBasiliximabbusiness.industryHazard ratioPopulationTacrolimuslaw.inventionTransplantationRandomized controlled triallawInternal medicinemedicineObservational studybusinesseducationSurvival ratemedicine.drugSSRN Electronic Journal
researchProduct

The prevalence of bipolar disorders in the general population - a growing trending topic?

2015

report the first meta-analysis of theprevalence of bipolar disorder (BD) from population-based studies. Strengths of the manuscript include theuse of suitable methods of analysis, reporting both annualand lifetime prevalence rates, and providing separatedata for bipolar subtypes I and II. The latter is relevantbecause type II is not simply a milder or minor form of BD.This publication is of considerable interest, firstlybecause it confirms that the frequency of BD in thegeneral population is low and closer to the conservativeestimates of 1-2%, as suggested by historical data.

medicine.medical_specialtyeducation.field_of_studyBipolar Disorderlcsh:RC435-571PopulationLifetime prevalencemedicine.diseasePsychiatry and Mental healthlcsh:PsychiatrymedicineHumansBipolar disorderPsiquiatriaPsychiatryeducationPsychology
researchProduct

The impact of grouping patients by the 2017 GOLD COPD strategy on response to therapy: post hoc results from the TONADO tiotropium+olodaterol trials

2017

Introduction: In the 2017 GOLD COPD strategy the classification of patients by assessment of symptoms and history of exacerbation is used to guide treatment choices. The previous strategy also included lung function. Aims and objectives: To investigate the effect of the 2017 classification on an analysis of the efficacy of tiotropium+olodaterol (T+O) in GOLD stage A/B patients with COPD. Methods: Patients from the Phase III, replicate 52-week TONADO studies (NCT01431274, NCT01431287), who received T+O or the mono-components, were classed as GOLD A/B or C/D by the 2017 strategy (using exacerbation history) or 2014 strategy (using lung function and exacerbation history). Since mMRC Dyspnoea S…

medicine.medical_specialtyeducation.field_of_studyCOPDResponse to therapyExacerbationPost hocbusiness.industryOlodaterolPopulationTiotropium-olodaterolmedicine.diseaserespiratory tract diseaseschemistry.chemical_compoundchemistryInternal medicineMedicinebusinesseducationLung functionClinical Problems COPD
researchProduct

Epidemiology and Cancer Prevention

2021

Cancer registries (CR) are essential structures for the recording of neoplasms in order to study their distribution and characteristics among a given population; this, moreover, can help in identifying possible main risk factors linked to some cancer conditions. Prevention nowadays is a fundamental key strategy for the control of neoplasms, and this is the reason why policies and screening programs should be implemented in order to raise awareness and reduce exposure to risk factors.

medicine.medical_specialtyeducation.field_of_studyCancer preventionbusiness.industryEnvironmental healthEpidemiologyPopulationScreening programsMedicineCancerbusinesseducationmedicine.disease
researchProduct

The cost of adverse event management in patients with RAS wild-type metastatic colorectal cancer treated with first-line cetuximab and panitumumab: A…

2019

Abstract Background In Italy, previously untreated patients with RAS wild-type metastatic colorectal cancer (mCRC) may receive an epidermal growth factor receptor (EGFR) inhibitor with a chemotherapy regimen (CT). The choice of anti-EGFR, either cetuximab (cet+CT) or panitumumab (pan+CT), depends on various factors, including adverse event (AE) profiles. Although AE profiles will evolve with increasing use and familiarity, the differences in AE profiles can be explored using literature and safety data from the summary of product characteristics (SmPC). The financial impact of these differences on the Italian National Health Service has yet to be estimated. Methods We developed a model to es…

medicine.medical_specialtyeducation.field_of_studyCetuximabbusiness.industryColorectal cancerPopulationHematologymedicine.diseaseChemotherapy regimenOncologyInternal medicineHealth caremedicinePanitumumabSummary of Product CharacteristicsAdverse effectbusinesseducationmedicine.drugAnnals of Oncology
researchProduct

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epiru…

2019

Background Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the docetaxel-based triplet FLOT (fluorouracil plus leucovorin, oxaliplatin and docetaxel) as a perioperative therapy for patients with locally advanced, resectable tumours. Methods In this controlled, open-label, phase 2/3 trial, we randomly assigned 716 patients with histologically-confirmed advanced clinical stage cT2 or higher or nodal positive stage (cN+), or both, resectable tumours, with no evidence of distant metastases, via central interactive web-based-response system, to receive either three pre-operative and t…

medicine.medical_specialtyeducation.field_of_studyChemotherapybusiness.industrymedicine.medical_treatmentPopulationMedizinGeneral MedicinePerioperative030204 cardiovascular system & hematologyGastroenterologyOxaliplatinCapecitabine03 medical and health sciences0302 clinical medicineDocetaxelFluorouracilInternal medicineMedicine030212 general & internal medicinebusinesseducationmedicine.drugEpirubicinThe Lancet
researchProduct

Surgery vs. chemotherapy for ovarian cancer recurrence: what is the best treatment option

2020

Nowadays, the best treatment option for ovarian cancer recurrence is often subjective, can vary in the different centers and depend on personal experience. Arbeitsgemeinschaft Gynaekologische Onkologie (AGO)-DESKTOP studies have identified a population of patients who could benefit from secondary surgery. The results of the Gynecologic Oncology Group (GOG)-0213 study were recently published, which showed no advantage in terms of overall survival (OS) in patients with platinum-sensitive recurrent epithelial ovarian undergoing secondary cytoreductive surgery (SCS) compared to chemotherapy alone. Aim of this narrative review is to summarize the best aspects that can make ovarian cancer recurre…

medicine.medical_specialtyeducation.field_of_studyChemotherapyendocrine system diseasesPerformance statusbusiness.industrymedicine.medical_treatmentPopulationTreatment optionsGynecologic oncologymedicine.diseaseSurgery03 medical and health sciences0302 clinical medicineRecurrent Ovarian Cancer030220 oncology & carcinogenesismedicineSurgery030212 general & internal medicineOvarian cancereducationbusinessContraindicationGland Surgery
researchProduct

Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrom…

2013

Thrombophilic genetic factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A were studied as risk factors in 235 Caucasian subjects: 85 patients with abdominal thrombosis (54 with portal vein thrombosis (PVT) and 31 with Budd-Chiari syndrome (BCS) without liver cirrhosis or hepatocellular carcinoma) and 150 blood bank donors. Seventy-five patients with PVT/BCS showed associated disease or particular clinical status (46 PVT/29 BCS): 37 myeloproliferative neoplasm (20 PVT/17 BCS), 12 abdominal surgery (10 PVT/2 BCS), 10 contraception or pregnancy (6 PVT/4 BCS), 7 abdominal acute disease (6 PVT/1 BCS), and 9 chronic disease (4 PVT/5 BCS); ten patients did not present any association …

medicine.medical_specialtyeducation.field_of_studyCirrhosisArticle Subjectbusiness.industryPopulationmedicine.diseaseGastroenterologyThrombosisPortal vein thrombosisSurgeryHepatocellular carcinomaInternal medicineRC666-701Budd–Chiari syndromemedicineClinical StudyDiseases of the circulatory (Cardiovascular) systemCardiology and Cardiovascular MedicinebusinesseducationMyeloproliferative neoplasmAbdominal surgeryInternational Journal of Vascular Medicine
researchProduct

Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels

2008

Abstract A persistent increase in non-virus non-alcohol related aminostransferase levels can have multiple causes, which differ in terms of prevalence and clinical importance. In the general population, the most frequent cause is non-alcoholic hepatic steatosis, which can evolve into steato-hepatitis and cirrhosis. The treatment for steatosis and non-alcoholic steato-hepatitis consists of modifying lifestyles, whereas the effectiveness of drug treatment remains to be determined. Other much less frequent (yet not rare) causes of persistent non-virus non-alcohol related elevations in aminotransferase levels are celiac disease and hemochromatosis, whereas autoimmune hepatitis, primary biliary …

medicine.medical_specialtyeducation.field_of_studyCirrhosisHepatologybusiness.industryPopulationGastroenterologyAutoimmune hepatitisDiseasemedicine.diseaseAsymptomaticPrimary sclerosing cholangitisPrimary biliary cirrhosisInternal medicineImmunologyEpidemiologyMedicinemedicine.symptombusinesseducationDigestive and Liver Disease
researchProduct

Biochemical biomarkers of NAFLD/NASH

2020

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the Western world and the global epidemics of obesity and type 2 diabetes have led to a dramatic increase of its prevalence and incidence. Among NAFLD patients, those with nonalcoholic steatohepatitis (NASH) have a double risk of fibrosis progression, that is the main driver toward the evolution in cirrhosis and its complications, including hepatocellular carcinoma and hepatic decompensation. Furthermore, patients with NAFLD are also at risk for cardiovascular diseases and extrahepatic malignancies, that represent the first and the second cause of death, respectively. The availability of non-invasi…

medicine.medical_specialtyeducation.field_of_studyCirrhosisSteatosismedicine.diagnostic_testbusiness.industryPopulationNASHLiver fibrosiType 2 diabetesmedicine.diseaseChronic liver diseaseGastroenterologydigestive system diseasesLiver biopsyInternal medicineHepatocellular carcinomaNAFLDNonalcoholic fatty liver diseasemedicinebusinesseducationNon-invasive assessmentCause of death
researchProduct